The strong associations between the loss of MAP4K5 expression and loss of E-cadherin or reduced CES2 expression may suggest an important role of MAP4K5 in epithelial-to-mesenchymal transition, chemotherapy resistance and tumor progression in pancreatic cancer. This evidence concerns the gene CDH1 and familial pancreatic carcinoma.